UNSPSC 51343305: Omaciclovir

This classification denotes an antiviral agent with the molecular formula C10H15N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C9H909GLI3, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-2-(hydroxymethyl)butyl)- (r)-; but generally known as omaciclovir, which bears US NIH Compound Identifier 3047801. The term OMACICLOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). Most nations schedule omaciclovir under HS 29335995 and SITC 51576.

As of Q4 2014, OMACICLOVIR remains the US FDA Preferred Term for this commodity. Omaciclovir bears US NLM identifiers UMLS ID C2983879 and NCI Concept Code C90785. SMILES: C1=NC2=C(N1CC(CCO)CO)NC(=NC2=O)N.

UNSPSC 51343305 Omaciclovir, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the code's pharmaceutical scope. The recent opportunities tagged under this code involve naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals through cooperative purchasing, and a direct-to-manufacturer prescription program inquiry — none of which target omaciclovir specifically. State and local governments posting under this code are primarily acquiring emergency medical supplies, OTC products, and generic pharmaceuticals through competitive bidding and cooperative purchasing arrangements rather than antiviral medications by name.

The issuing bodies include county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), state health and human services agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local jurisdictions including Oregon). Recent solicitations include Seminole County's IFB for naloxone and drug deactivation systems with quarterly deliveries due by July 26, 2023; the City of Tampa's invitation to bid for medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000 and designated as a sheltered market for certified Small Local Business Enterprises; the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products due March 26, 2026, serving state and local government facilities across multiple jurisdictions; and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs posted April 3, 2026. Activity spans Florida, Texas, Minnesota, and Oregon. The code exhibits limited relevance to omaciclovir procurement specifically and may signal either low demand for this antiviral at the state and local level or a tagging mismatch in procurement systems.